Skip to main content
Fig. 5 | BMC Bioinformatics

Fig. 5

From: Multiscale modeling reveals angiogenesis-induced drug resistance in brain tumors and predicts a synergistic drug combination targeting EGFR and VEGFR pathways

Fig. 5

Vascular tumor growth patterns at different time points under treatment with the EGFR inhibitor combined with the VEGFR inhibitor at 240 h. a Vascular tumor growth patterns at 240 h; b Vascular tumor growth patterns at 310 h; c Vascular tumor growth patterns at 380 h; d Vascular tumor growth patterns at 450 h. e Changes in the numbers of various cells in response to the combined VEGFRI and EGFRI treatment. VEGFRI was added at 240 h

Back to article page

BMC Bioinformatics

ISSN: 1471-2105

Contact us